The intracellular sensor NOD2 induces microrna-29 expression in human dendritic cells to limit IL-23 release

Immunity

Volumn 39, Issue 3, 2013, Pages 521-536

  Brain, Oliver ^a,b   Owens, Benjamin M J ^a   Pichulik, Tica ^b   Allan, Philip ^a,b   Khatamzas, Elham ^b   Leslie, Alasdair ^b   Steevels, Tessa ^a,b   Sharma, Sameer ^a,b   Mayer, Alice ^b   Catuneanu, Ana Maria ^a,b   Morton, Victoria ^a,b   Sun, Mei Yi ^b   Jewell, Derek ^a   Coccia, Margherita ^c   Harrison, Oliver ^c   Maloy, Kevin ^c   Schönefeldt, Susann ^d,e   Bornschein, Simon ^d,e   Liston, Adrian ^d,e   Simmons, Alison ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 23P19; MICRORNA 29; PATTERN RECOGNITION RECEPTOR;

ARTICLE; COLITIS; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; DENDRITIC CELL; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 2; ANIMALS; CELLS, CULTURED; CROHN DISEASE; DENDRITIC CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INFLAMMATION; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; MICRORNAS; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; TH17 CELLS;

EID: 84884315797     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.08.035     Document Type: Article

References (55)

1. Ahern P.P., Schiering C., Buonocore S., McGeachy M.J., Cua D.J., Maloy K.J., Powrie F. Interleukin-23 drives intestinal inflammation through direct activity on Tcells. Immunity 2010, 33:279-288.
2. Al-Salleeh F., Petro T.M. Promoter analysis reveals critical roles for SMAD-3 and ATF-2 in expression of IL-23 p19 in macrophages. J.Immunol. 2008, 181:4523-4533.
3. Aliberti J., Viola J.P., Vieira-de-Abreu A., Bozza P.T., Sher A., Scharfstein J. Cutting edge: bradykinin induces IL-12 production by dendritic cells: a danger signal that drives Th1 polarization. J.Immunol. 2003, 170:5349-5353.
4. Banisor I., Leist T.P., Kalman B. Involvement of beta-chemokines in the development of inflammatory demyelination. J.Neuroinflammation 2005, 2:7.
5. Bazzini A.A., Lee M.T., Giraldez A.J. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 2012, 336:233-237.
6. Bazzoni F., Rossato M., Fabbri M., Gaudiosi D., Mirolo M., Mori L., Tamassia N., Mantovani A., Cassatella M.A., Locati M. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. USA 2009, 106:5282-5287.
7. Becker C., Wirtz S., Blessing M., Pirhonen J., Strand D., Bechthold O., Frick J., Galle P.R., Autenrieth I., Neurath M.F. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J.Clin. Invest. 2003, 112:693-706.
8. Buonocore S., Ahern P.P., Uhlig H.H., Ivanov I.I., Littman D.R., Maloy K.J., Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464:1371-1375.
9. Ceppi M., Pereira P.M., Dunand-Sauthier I., Barras E., Reith W., Santos M.A., Pierre P. MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proc. Natl. Acad. Sci. USA 2009, 106:2735-2740.
10. Codarri L., Gyülvészi G., Tosevski V., Hesske L., Fontana A., Magnenat L., Suter T., Becher B. RORγt drives production of the cytokine GM-CSF in helper Tcells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011, 12:560-567.
11. Cooney R., Baker J., Brain O., Danis B., Pichulik T., Allan P., Ferguson D.J., Campbell B.J., Jewell D., Simmons A. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 2010, 16:90-97.
12. Cuthbert A.P., Fisher S.A., Mirza M.M., King K., Hampe J., Croucher P.J., Mascheretti S., Sanderson J., Forbes A., Mansfield J., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002, 122:867-874.
13. Darfeuille-Michaud A., Boudeau J., Bulois P., Neut C., Glasser A.L., Barnich N., Bringer M.A., Swidsinski A., Beaugerie L., Colombel J.F. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004, 127:412-421.
14. Djuranovic S., Nahvi A., Green R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012, 336:237-240.
15. Driesen J., Popov A., Schultze J.L. CD25 as an immune regulatory molecule expressed on myeloid dendritic cells. Immunobiology 2008, 213:849-858.
16. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. USA 2007, 104:15805-15810.
17. Franke A., McGovern D.P., Barrett J.C., Wang K., Radford-Smith G.L., Ahmad T., Lees C.W., Balschun T., Lee J., Roberts R., et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Genet. 2010, 42:1118-1125.
18. Geremia A., Arancibia-Cárcamo C.V., Fleming M.P., Rust N., Singh B., Mortensen N.J., Travis S.P., Powrie F. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J.Exp. Med. 2011, 208:1127-1133.
19. Griseri T., McKenzie B.S., Schiering C., Powrie F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 2012, 37:1116-1129.
20. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J.Biol. Chem. 2003, 278:5509-5512.
21. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nuñez G., Flavell R.A. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734.
22. Lapaquette P., Bringer M.A., Darfeuille-Michaud A. Defects in autophagy favour adherent-invasive Escherichia coli persistence within macrophages leading to increased pro-inflammatory response. Cell. Microbiol. 2012, 14:791-807.
23. Liu Z., Yadav P.K., Xu X., Su J., Chen C., Tang M., Lin H., Yu J., Qian J., Yang P.C., Wang X. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J.Leukoc. Biol. 2011, 89:597-606.
24. Lu C., Huang X., Zhang X., Roensch K., Cao Q., Nakayama K.I., Blazar B.R., Zeng Y., Zhou X. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011, 117:4293-4303.
25. Lyakh L., Trinchieri G., Provezza L., Carra G., Gerosa F. Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunol. Rev. 2008, 226:112-131.
26. Ma F., Xu S., Liu X., Zhang Q., Xu X., Liu M., Hua M., Li N., Yao H., Cao X. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat. Immunol. 2011, 12:861-869.
27. Martinez-Medina M., Aldeguer X., Lopez-Siles M., González-Huix F., López-Oliu C., Dahbi G., Blanco J.E., Blanco J., Garcia-Gil L.J., Darfeuille-Michaud A. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm. Bowel Dis. 2009, 15:872-882.
28. Matteoli G., Mazzini E., Iliev I.D., Mileti E., Fallarino F., Puccetti P., Chieppa M., Rescigno M. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010, 59:595-604.
29. Maurer B., Stanczyk J., Jüngel A., Akhmetshina A., Trenkmann M., Brock M., Kowal-Bielecka O., Gay R.E., Michel B.A., Distler J.H., et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum. 2010, 62:1733-1743.
30. Mott J.L., Kobayashi S., Bronk S.F., Gores G.J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140.
31. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 2005, 6:769-776.
32. Noguchi E., Homma Y., Kang X., Netea M.G., Ma X. A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat. Immunol. 2009, 10:471-479.
33. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 2007, 104:1604-1609.
34. O'Connell R.M., Kahn D., Gibson W.S., Round J.L., Scholz R.L., Chaudhuri A.A., Kahn M.E., Rao D.S., Baltimore D. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory Tcell development. Immunity 2010, 33:607-619.
35. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J.Biol. Chem. 2001, 276:4812-4818.
36. Papadopoulou A.S., Dooley J., Linterman M.A., Pierson W., Ucar O., Kyewski B., Zuklys S., Hollander G.A., Matthys P., Gray D.H., et al. The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor. Nat. Immunol. 2012, 13:181-187.
37. Plantinga T.S., Crisan T.O., Oosting M., van de Veerdonk F.L., de Jong D.J., Philpott D.J., van der Meer J.W., Girardin S.E., Joosten L.A., Netea M.G. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut 2011, 60:1229-1235.
38. Polidoros A.N., Mylona P.V., Arnholdt-Schmitt B. Aox gene structure, transcript variation and expression in plants. Physiol. Plant. 2009, 137:342-353.
39. Rehman A., Sina C., Gavrilova O., Häsler R., Ott S., Baines J.F., Schreiber S., Rosenstiel P. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011, 60:1354-1362.
40. Rescigno M., Urbano M., Valzasina B., Francolini M., Rotta G., Bonasio R., Granucci F., Kraehenbuhl J.P., Ricciardi-Castagnoli P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001, 2:361-367.
41. Roderburg C., Urban G.W., Bettermann K., Vucur M., Zimmermann H., Schmidt S., Janssen J., Koppe C., Knolle P., Castoldi M., et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:209-218.
42. Seiderer J., Brand S., Herrmann K.A., Schnitzler F., Hatz R., Crispin A., Pfennig S., Schoenberg S.O., Göke B., Lohse P., Ochsenkuhn T. Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study. Inflamm. Bowel Dis. 2006, 12:1114-1121.
43. Sheedy F.J., Palsson-McDermott E., Hennessy E.J., Martin C., O'Leary J.J., Ruan Q., Johnson D.S., Chen Y., O'Neill L.A. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 2010, 11:141-147.
44. Steiner D.F., Thomas M.F., Hu J.K., Yang Z., Babiarz J.E., Allen C.D., Matloubian M., Blelloch R., Ansel K.M. MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper Tcells. Immunity 2011, 35:169-181.
45. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103:12481-12486.
46. Tili E., Michaille J.J., Cimino A., Costinean S., Dumitru C.D., Adair B., Fabbri M., Alder H., Liu C.G., Calin G.A., Croce C.M. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J.Immunol. 2007, 179:5082-5089.
47. Travassos L.H., Carneiro L.A., Ramjeet M., Hussey S., Kim Y.G., Magalhães J.G., Yuan L., Soares F., Chea E., Le Bourhis L., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 2010, 11:55-62.
48. Uehara A., Yang S., Fujimoto Y., Fukase K., Kusumoto S., Shibata K., Sugawara S., Takada H. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 2005, 7:53-61.
49. Uhlig H.H., McKenzie B.S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., Robinson N., Buonocore S., Tlaskalova-Hogenova H., Cua D.J., Powrie F. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006, 25:309-318.
50. van Beelen A.J., Zelinkova Z., Taanman-Kueter E.W., Muller F.J., Hommes D.W., Zaat S.A., Kapsenberg M.L., de Jong E.C. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory Tcells. Immunity 2007, 27:660-669.
51. van Heel D.A., Ghosh S., Hunt K.A., Mathew C.G., Forbes A., Jewell D.P., Playford R.J. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 2005, 54:1553-1557.
52. Vautier S., Sousa Mda.G., Brown G.D. C-type lectins, fungi and Th17 responses. Cytokine Growth Factor Rev. 2010, 21:405-412.
53. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schäffeler E., Schlee M., Herrlinger K.R., Stallmach A., Noack F., Fritz P., et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004, 53:1658-1664.
54. Yang S., Tamai R., Akashi S., Takeuchi O., Akira S., Sugawara S., Takada H. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 2001, 69:2045-2053.
55. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., et al. IL-23 is essential for Tcell-mediated colitis and promotes inflammation via IL-17 and IL-6. J.Clin. Invest. 2006, 116:1310-1316.